These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1271 related items for PubMed ID: 23395909

  • 1. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G, Tchidjou HK, Pontrelli G, Bernardi S, D'Ettorre G, Vullo V, Buonomini AR, Andreoni M, Santoni A, Cerboni C, Doria M.
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [Abstract] [Full Text] [Related]

  • 2. Proteolytic release of soluble UL16-binding protein 2 from tumor cells.
    Waldhauer I, Steinle A.
    Cancer Res; 2006 Mar 01; 66(5):2520-6. PubMed ID: 16510567
    [Abstract] [Full Text] [Related]

  • 3. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.
    Raffaghello L, Prigione I, Airoldi I, Camoriano M, Levreri I, Gambini C, Pende D, Steinle A, Ferrone S, Pistoia V.
    Neoplasia; 2004 Mar 01; 6(5):558-68. PubMed ID: 15548365
    [Abstract] [Full Text] [Related]

  • 4. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
    Song H, Kim J, Cosman D, Choi I.
    Cell Immunol; 2006 Jan 01; 239(1):22-30. PubMed ID: 16630603
    [Abstract] [Full Text] [Related]

  • 5. Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ?
    Giuliani E, Vassena L, Cerboni C, Doria M.
    Curr Drug Targets; 2016 Jan 01; 17(1):54-64. PubMed ID: 26122035
    [Abstract] [Full Text] [Related]

  • 6. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
    Paschen A, Sucker A, Hill B, Moll I, Zapatka M, Nguyen XD, Sim GC, Gutmann I, Hassel J, Becker JC, Steinle A, Schadendorf D, Ugurel S.
    Clin Cancer Res; 2009 Aug 15; 15(16):5208-15. PubMed ID: 19671853
    [Abstract] [Full Text] [Related]

  • 7. Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway.
    Le Maux Chansac B, Missé D, Richon C, Vergnon I, Kubin M, Soria JC, Moretta A, Chouaib S, Mami-Chouaib F.
    Int Immunol; 2008 Jul 15; 20(7):801-10. PubMed ID: 18441340
    [Abstract] [Full Text] [Related]

  • 8. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, Nausch N, Tuettenberg J, Steinle A, Cerwenka A, Schadendorf D, Paschen A.
    Int J Cancer; 2009 Apr 01; 124(7):1594-604. PubMed ID: 19089914
    [Abstract] [Full Text] [Related]

  • 9. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
    Cox ST, Danby R, Hernandez D, Laza-Briviesca R, Pearson H, Madrigal JA, Saudemont A.
    Front Immunol; 2018 Apr 01; 9():1282. PubMed ID: 29963042
    [Abstract] [Full Text] [Related]

  • 10. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.
    Chitadze G, Bhat J, Lettau M, Janssen O, Kabelitz D.
    Scand J Immunol; 2013 Aug 01; 78(2):120-9. PubMed ID: 23679194
    [Abstract] [Full Text] [Related]

  • 11. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.
    Raneros AB, Minguela A, Rodriguez RM, Colado E, Bernal T, Anguita E, Mogorron AV, Gil AC, Vidal-Castiñeira JR, Márquez-Kisinousky L, Bulnes PD, Marin AM, Garay MCG, Suarez-Alvarez B, Lopez-Larrea C.
    Oncotarget; 2017 May 09; 8(19):31959-31976. PubMed ID: 28404876
    [Abstract] [Full Text] [Related]

  • 12. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
    Pende D, Rivera P, Marcenaro S, Chang CC, Biassoni R, Conte R, Kubin M, Cosman D, Ferrone S, Moretta L, Moretta A.
    Cancer Res; 2002 Nov 01; 62(21):6178-86. PubMed ID: 12414645
    [Abstract] [Full Text] [Related]

  • 13. NKG2D ligands expression and NKG2D-mediated NK activity in Sezary patients.
    Dulphy N, Berrou J, Campillo JA, Bagot M, Bensussan A, Toubert A.
    J Invest Dermatol; 2009 Feb 01; 129(2):359-64. PubMed ID: 18754036
    [Abstract] [Full Text] [Related]

  • 14. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
    Rölle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Söderberg-Nauclér C, Cosman D, Kärre K, Cerboni C.
    J Immunol; 2003 Jul 15; 171(2):902-8. PubMed ID: 12847260
    [Abstract] [Full Text] [Related]

  • 15. Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells.
    Cerboni C, Ardolino M, Santoni A, Zingoni A.
    Blood; 2009 Mar 26; 113(13):2955-64. PubMed ID: 19124832
    [Abstract] [Full Text] [Related]

  • 16. Altered NK-cell compartment and dysfunctional NKG2D/NKG2D-ligand axis in patients with ataxia-telangiectasia.
    Desimio MG, Finocchi A, Di Matteo G, Di Cesare S, Giancotta C, Conti F, Chessa L, Piane M, Montin D, Dellepiane M, Rossi P, Cancrini C, Doria M.
    Clin Immunol; 2021 Sep 26; 230():108802. PubMed ID: 34298181
    [Abstract] [Full Text] [Related]

  • 17. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.
    Wittenbrink M, Spreu J, Steinle A.
    Eur J Immunol; 2009 Jun 26; 39(6):1642-51. PubMed ID: 19424970
    [Abstract] [Full Text] [Related]

  • 18. Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses.
    Hilpert J, Grosse-Hovest L, Grünebach F, Buechele C, Nuebling T, Raum T, Steinle A, Salih HR.
    J Immunol; 2012 Aug 01; 189(3):1360-71. PubMed ID: 22730533
    [Abstract] [Full Text] [Related]

  • 19. Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell.
    Bae DS, Hwang YK, Lee JK.
    Cell Immunol; 2012 Aug 01; 276(1-2):122-7. PubMed ID: 22613008
    [Abstract] [Full Text] [Related]

  • 20. Corticotropin-releasing factor induces immune escape of cervical cancer cells by downregulation of NKG2D.
    Song H, Park H, Park G, Kim YS, Lee HK, Jin DH, Kang HS, Cho DH, Hur D.
    Oncol Rep; 2014 Jul 01; 32(1):425-30. PubMed ID: 24841552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.